RxDoctor Payments Data

Mylene James, NP

Nurse Practitioner · Decatur, GANPI 1184931313

Payments from drug & device makers

$7,619in general payments, 2019–2025

Across 229 payments — averaging $33.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$584
  • Johnson & Johnson$551
  • Daiichi Sankyo Inc.$441
  • Incyte Corporation$390
  • Astellas Pharma US Inc$320
  • Novartis$307
  • plus $5K from 54 others

What the payments were for

  • Food & beverage$6,50985%
  • Education$1,11015%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca(2 entities)21$584
Johnson & Johnson16$551
Daiichi Sankyo Inc.13$441
Incyte Corporation10$390
Astellas Pharma US Inc4$320
Novartis8$307
Bristol Myers Squibb11$273
Merck11$273
Caris MPI, Inc.5$260
Gilead8$245
Eisai Inc.5$207
Seagen Inc.3$202
Jazz Pharmaceuticals Inc.4$195
Karyopharm Therapeutics Inc.3$176
Bayer4$165
Sobi, Inc3$148
Pfizer8$144
Morphosys, US Inc.1$140
Pharmacyclics LLC, An Abbvie Company2$135
AbbVie6$135
Takeda Pharmaceuticals U.S.A., Inc.4$134
GSK6$125
Exelixis Inc.2$118
Geron Corporation2$118
Syndax Pharmaceuticals, Inc.2$116
Coherus Oncology, Inc.3$114
Genentech USA, Inc.6$113
Beone Medicines USA, Inc.4$101
Tempus AI, Inc4$92
Regeneron Healthcare Solutions, Inc.3$90
Sanofi3$89
CTI Biopharma Corp.1$89
Puma Biotechnology, Inc.1$78
Janssen Scientific Affairs, LLC1$63
Stemline Therapeutics Inc.3$62
Tersera Therapeutics LLC2$62
Invivyd Inc2$60
Immunocore Limited3$54
AVEO Pharmaceuticals, Inc.2$50
Beigene USA, Inc.2$49
Servier Pharmaceuticals LLC2$45
Lilly USA, LLC2$43
ADC Therapeutics America, Inc.2$43
Array Biopharma Inc4$42
Boston Scientific1$36
Deciphera Pharmaceuticals Inc.1$35
Agios Pharmaceuticals, Inc.2$34
Nuvation Bio Inc.1$32
Pharmaessentia USA Corporation1$27
Boehringer Ingelheim1$23
Ipsen Biopharmaceuticals, Inc1$23
Legend Biotech USA Inc.1$20
Adaptive Biotechnologies Corporation1$20
Acrotech Biopharma Inc.1$19
Pharmacosmos Therapeutics Inc.1$19
E.r. Squibb & Sons, L.L.C.1$18
Foundation Medicine, Inc.1$18
Sumitomo Pharma America, Inc.1$18
Springworks Therapeutics, Inc.1$17
Corcept Therapeutics1$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,619 in reported general payments places this provider in the 95th percentile of 3,328 nurse practitioner providers in Georgia.

See all nurse practitioner providers in Georgia

Medicare billing

Part B allowed, 2024
$1,688
Medicare patients
22
Services billed
36

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Pregabalin78$1,722
Tramadol Hcl85$408
Diphenoxylate-AtropineDiphenoxylate Hcl/Atropine26$315
Zolpidem Tartrate40$182
Lorazepam38$76
Alprazolam17$69

Paid to pharmacies, not to this prescriber.

Other nurse practitioner in Decatur

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →